These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1173 related items for PubMed ID: 16366159

  • 1. Cardioprotection by aldosterone receptor antagonism in heart failure. Part I. The role of aldosterone in heart failure.
    Dieterich HA, Wendt C, Saborowski F.
    Fiziol Cheloveka; 2005; 31(6):97-105. PubMed ID: 16366159
    [Abstract] [Full Text] [Related]

  • 2. Aldosterone antagonism in addition to angiotensin-converting enzyme inhibitors in heart failure.
    Bauersachs J, Fraccarollo D.
    Minerva Cardioangiol; 2003 Apr; 51(2):155-64. PubMed ID: 12783071
    [Abstract] [Full Text] [Related]

  • 3. Aldosterone antagonists in congestive heart failure.
    Soberman J, Chafin CC, Weber KT.
    Curr Opin Investig Drugs; 2002 Jul; 3(7):1024-8. PubMed ID: 12186262
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 6. Aldosterone blockade in heart failure.
    Struthers AD.
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5 Suppl 1():S23-7. PubMed ID: 15526239
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Induction of cardiac fibrosis by aldosterone.
    Lijnen P, Petrov V.
    J Mol Cell Cardiol; 2000 Jun; 32(6):865-79. PubMed ID: 10888242
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 13. [The AREA IN-CHF trial (antiremodeling effect of aldosterone receptors blockade with canrenone in mild chronic heart failure): rationale and design].
    Cacciatore G, Boccanelli A, Mureddu GF, Maggioni AP, Latini R, Masson S, de Simone G, Investigatori dell' Area In-CHF.
    Ital Heart J; 2005 May; 6 Suppl 1():66S-74S. PubMed ID: 15945301
    [Abstract] [Full Text] [Related]

  • 14. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
    Makkar KM, Sanoski CA, Spinler SA.
    Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
    [Abstract] [Full Text] [Related]

  • 15. [The significance of aldosterone in chronic heart failure: the RALES study].
    Simko F, Bada V, Simková M, Simko J, Kovács L, Hulín I.
    Vnitr Lek; 2002 Aug; 48(8):767-72. PubMed ID: 12425209
    [Abstract] [Full Text] [Related]

  • 16. Suppression of the renin-angiotensin-aldosterone system in chronic heart failure: choice of agents and clinical impact.
    Jorde UP.
    Cardiol Rev; 2006 Aug; 14(2):81-7. PubMed ID: 16493245
    [Abstract] [Full Text] [Related]

  • 17. Blockade of renin-angiotensin-aldosterone system in kidney and heart disease: how much do we need?
    Lim S.
    Acta Med Indones; 2008 Jan; 40(1):34-7. PubMed ID: 19054878
    [Abstract] [Full Text] [Related]

  • 18. Aldosterone antagonists in hypertension and heart failure.
    Mantero F, Lucarelli G.
    Ann Endocrinol (Paris); 2000 Feb; 61(1):52-60. PubMed ID: 10790593
    [Abstract] [Full Text] [Related]

  • 19. [Anti-aldosterone therapy in severe heart failure].
    van Guldener C, Donker AJ.
    Ned Tijdschr Geneeskd; 1999 Aug 21; 143(34):1724-6. PubMed ID: 10494316
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 59.